Neuropathix Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Reverse Merger

  • Investors
  • 1

Neuropathix General Information

Description

Developer of therapeutic novel molecules designed to reduce neurodegenerative and oxidative stress and act as immuno-modulators and neuroprotectants. The company specializes in research, development and discovery of patented novel nanotherapeutic agents for targeted drug candidates to treat Chemotherapy Induced Peripheral Neuropathy, Hepatic Encephalopathy, Mild Traumatic Brain Injury and chronic pain management to treat patients with a variety of unmet medical needs.

Contact Information

Website
www.neuropathix.com
Formerly Known As
KannaLife Sciences, Inc., Tyg Solutions Inc., Kannalife Inc, KannaLife Sciences
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 3805 Old Easton Road
  • Pennsylvania Biotechnology Center
  • Doylestown, PA 18902
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Cannabis, Life Sciences
Corporate Office
  • 3805 Old Easton Road
  • Pennsylvania Biotechnology Center
  • Doylestown, PA 18902
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuropathix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Reverse Merger 25-Jul-2018 Completed Generating Revenue
4. Later Stage VC (Series B) 25-Feb-2016 Cancelled Pre-Clinical Trials
3. Angel (individual) 01-May-2015 Completed Startup
2. Secondary Transaction - Private 20-Jun-2014 $1.5M Completed Startup
1. Early Stage VC (Series A) 07-Mar-2013 $1.5M $1.5M Completed Startup
To view Neuropathix’s complete valuation and funding history, request access »

Neuropathix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic novel molecules designed to reduce neurodegenerative and oxidative stress and act as immuno-mod
Drug Discovery
Doylestown, PA
6 As of 2021

Barcelona, Spain
 

Clarksville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuropathix Competitors (57)

One of Neuropathix’s 57 competitors is Ability Pharma, a Private Equity-Backed company based in Barcelona, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Private Equity-Backed Barcelona, Spain
NeuroNascent Venture Capital-Backed Clarksville, MD
Mitochon Pharmaceuticals Venture Capital-Backed Blue Bell, PA
Hapten Sciences Venture Capital-Backed Memphis, TN
Mitobridge Formerly VC-backed Cambridge, MA
You’re viewing 5 of 57 competitors. Get the full list »

Neuropathix Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Neuropathix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240131004-A1 Functionalized 1,3-benzene diols and their method of use for the treatment of inflammation and pain Pending 01-Feb-2021
US-20220409578-A1 Functionalized 1,3-benzene diols and their method of use for the treatment of radiation dermatitis and other skin disorders Pending 13-Nov-2019
CA-3145418-A1 Use of certain phosphatidylcholines containing long chain polyunsaturated fatty acids as neuroprotective agents Inactive 26-Jun-2019
US-20220257620-A1 Use of certain phosphatidylcholines containing long chain polyunsaturated fatty acids as neuroprotective agents Inactive 26-Jun-2019
ES-2791291-T3 New functionalized 1,3-benzenediols and their method of use for the treatment of hepatic encephalopathy Active 13-Jan-2014 C07D205/04
To view Neuropathix’s complete patent history, request access »

Neuropathix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuropathix Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
TYG Solutions Corporation Minority
To view Neuropathix’s complete investors history, request access »

Neuropathix Acquisitions (1)

Neuropathix’s most recent deal was a Merger/Acquisition with TYG Solutions. The deal was made on 25-Jul-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TYG Solutions 25-Jul-2018 Merger/Acquisition Application Software
To view Neuropathix’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Neuropathix FAQs

  • When was Neuropathix founded?

    Neuropathix was founded in 2010.

  • Where is Neuropathix headquartered?

    Neuropathix is headquartered in Doylestown, PA.

  • What is the size of Neuropathix?

    Neuropathix has 6 total employees.

  • What industry is Neuropathix in?

    Neuropathix’s primary industry is Drug Discovery.

  • Is Neuropathix a private or public company?

    Neuropathix is a Private company.

  • What is Neuropathix’s current revenue?

    The current revenue for Neuropathix is .

  • How much funding has Neuropathix raised over time?

    Neuropathix has raised $1.5M.

  • Who are Neuropathix’s investors?

    TYG Solutions has invested in Neuropathix.

  • Who are Neuropathix’s competitors?

    Ability Pharma, NeuroNascent, Mitochon Pharmaceuticals, Hapten Sciences, and Mitobridge are some of the 57 competitors of Neuropathix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »